New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 16, 2018 - Allergan and Medicines360 announced the FDA approval of Liletta (levonorgestrel-releasing intrauterine system), for prevention of pregnancy for up to 5 years.
Download PDF
Return to publications
